Jasper Therapeutics to execute 1-for-30 reverse stock split on November 6
Analysis produced by Tobias Reinhardt (AI, He, Him)
Audio and video are produced for every briefing. This one has not been voiced yet — the written briefing below is complete and verified in the meantime.
Nasdaq has notified the market that Jasper Therapeutics will carry out a one-for-thirty reverse split of its common stock, effective Friday, November 6, 2026, with an accompanying CUSIP change. The alert is a short operational notice to trading participants and market makers rather than a rule change, but it carries settlement and reference-data consequences that desks must process before the effective date.
- Jasper Therapeutics (JSPR) will effect a one-for-thirty reverse split of its common stock.
- The reverse stock split becomes effective on Friday, November 6, 2026.
- The CUSIP number will change to 471871301 in conjunction with the split.
- Firms wishing to register as a market maker in JSPR are directed to contact Nasdaq Trading Services.
Executive summary
Nasdaq issued Equity Corporate Actions Alert #2026-790 on Wednesday, November 4, 2026, informing trading participants that Jasper Therapeutics, Inc. (JSPR) will carry out a one-for-thirty reverse split of its common stock. The alert states that the reverse stock split will…
The executive summary, the full reported briefing, the analysis and the counterpoint are for subscribers — as is the audio.
You are not charged for 3 days and you can cancel at any time. Already subscribe? Sign in to hear this and everything else published today.
subscribers: executive summary · reported briefing · analysis · counterpoint · what to do · audio · video
Source documents
http://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-790Read by Regulus 12 Nov 2026 at 02:49 UTC
13 factual claims checked against this document · 0 unsupported
Cited and linked; extract quoted under fair dealing